Claudio Fiocchi

Active 1979–2025

101
Papers
20,833
Citations
79
h-index
99
i10-index

Citations

Citations per year for Claudio Fiocchi1974: 1 citations1980: 1 citations1981: 2 citations1982: 2 citations1983: 1 citations1984: 5 citations1985: 5 citations1986: 13 citations1987: 4 citations1988: 16 citations1989: 20 citations1990: 14 citations1991: 13 citations1992: 24 citations1993: 13 citations1994: 11 citations1995: 16 citations1996: 12 citations1997: 36 citations1998: 79 citations1999: 89 citations2000: 96 citations2001: 95 citations2002: 136 citations2003: 117 citations2004: 118 citations2005: 158 citations2006: 172 citations2007: 154 citations2008: 154 citations2009: 135 citations2010: 143 citations2011: 176 citations2012: 120 citations2013: 159 citations2014: 182 citations2015: 174 citations2016: 170 citations2017: 179 citations2018: 171 citations2019: 635 citations2020: 632 citations2021: 725 citations2022: 636 citations2023: 503 citations2024: 784 citations2025: 373 citations2026: 12 citations1975–1979: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,006 citing papers, 22.2% of this breakdownChina: 1,308 citing papers, 14.5% of this breakdownGermany: 558 citing papers, 6.2% of this breakdownItaly: 546 citing papers, 6% of this breakdownUnited Kingdom: 522 citing papers, 5.8% of this breakdownCanada: 391 citing papers, 4.3% of this breakdownFrance: 317 citing papers, 3.5% of this breakdownJapan: 314 citing papers, 3.5% of this breakdownSpain: 224 citing papers, 2.5% of this breakdownNetherlands: 218 citing papers, 2.4% of this breakdownAustralia: 191 citing papers, 2.1% of this breakdownBelgium: 191 citing papers, 2.1% of this breakdown
0%22.2%Other 24.9%

Fields

  • Biochemistry, Genetics and Molecular Biology49.7%
  • Medicine25.8%
  • Immunology and Microbiology13.4%
  • Neuroscience3.3%
  • Nursing2.1%
  • Agricultural and Biological Sciences1.5%
  • Other4.2%

Topics

  • Inflammatory Bowel Disease14.2%
  • Gut microbiota and health5.5%
  • Microscopic Colitis3.9%
  • IL-33, ST2, and ILC Pathways3.3%
  • Immune Cell Function and Interaction2.3%
  • Helicobacter pylori-related gastroenterology studies2%
  • Other68.8%

Coauthors

All papers

Open in search
  1. Immunopathogenesis of IBD: current state of the art

    Authors: , - Nature Reviews Gastroenterology & Hepatology 2015 cited by 1,521

  2. Environmental triggers in IBD: a review of progress and evidence

    Authors: , , , , , , , - Nature Reviews Gastroenterology & Hepatology 2017 cited by 936

  3. Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases

    Authors: , , - Gastroenterology 2016 cited by 512

  4. Ulcerative Colitis

    Authors: , - New England Journal of Medicine 2011 cited by 1,092

  5. The IBD interactome: an integrated view of aetiology, pathogenesis and therapy

    Authors: , , - Nature Reviews Gastroenterology & Hepatology 2017 cited by 446

  6. Breaking the therapeutic ceiling in drug development in ulcerative colitis

    Authors: , , , - ˜The œLancet. Gastroenterology & hepatology 2021 cited by 212

  7. Fibrosis in IBD: from pathogenesis to therapeutic targets

    Authors: , , , , - Gut 2024 cited by 156

  8. Fibrosis in ulcerative colitis is directly linked to severity and chronicity of mucosal inflammation

    Authors: , , , , , , , , , , , - Alimentary Pharmacology & Therapeutics 2018 cited by 205

  9. Stricturing Crohn’s Disease Single-Cell RNA Sequencing Reveals Fibroblast Heterogeneity and Intercellular Interactions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan D. Holubar, Scott R. Steele, Claudio Fiocchi, Andrei I. Ivanov, Kellie M. Kravarik, Florian Rieder - Gastroenterology 2023 cited by 96

  10. Inflammation-Induced Endothelial-to-Mesenchymal Transition

    Authors: , , , , , , , , - American Journal Of Pathology 2011 cited by 314

  11. Novel mechanisms and clinical trial endpoints in intestinal fibrosis*

    Authors: , , , , , - Immunological Reviews 2021 cited by 111

  12. Inclusion of the Mesentery in Ileocolic Resection for Crohn’s Disease is Associated With Reduced Surgical Recurrence

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2018 cited by 349

  13. IL-36 in chronic inflammation and fibrosis — bridging the gap?

    Authors: , , , , , , , - Journal of Clinical Investigation 2021 cited by 111

  14. Intestinal fibrosis in IBD—a dynamic, multifactorial process

    Authors: , - Nature Reviews Gastroenterology & Hepatology 2009 cited by 339

  15. Activated intestinal muscle cells promote preadipocyte migration: a novel mechanism for creeping fat formation in Crohn’s disease

    Authors: , , , , , , , , , , , , , , , , , , , - Gut 2021 cited by 76

  16. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5

    Authors: , , , , , , , - The Journal of Immunology 1996 cited by 1,232

  17. Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 411

  18. A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn’s Disease and Human Gut Microbiome Composition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Håkon Håkonarson, Ramnik J. Xavier, Mark J. Daly, Steven R. Brant, John D. Rioux, Mark S. Silverberg, Judy H. Cho, Jonathan Braun, Dermot McGovern, Richard H. Duerr - Gastroenterology 2016 cited by 152

  19. Fibrosis in Ulcerative Colitis

    Authors: , , , , - Inflammatory Bowel Diseases 2014 cited by 137

  20. Selective deletion of MyD88 signaling in α-SMA positive cells ameliorates experimental intestinal fibrosis via post-transcriptional regulation

    Authors: , , , , , , , , , , , , , , , , , , - Mucosal Immunology 2020 cited by 57

  21. A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19

    Authors: , , , , , , , , , , , , , , , , , - PLoS Biology 2020 cited by 185

  22. Omics and Multi-Omics in IBD: No Integration, No Breakthroughs

    Authors: - International Journal of Molecular Sciences 2023 cited by 49

  23. Inflammatory bowel disease: Etiology and pathogenesis

    Authors: - Gastroenterology 1998 cited by 2,078

  24. Human intestinal myofibroblasts deposited collagen VI enhances adhesiveness for T cells – A novel mechanism for maintenance of intestinal inflammation

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Matrix Biology 2022 cited by 33